Status:
UNKNOWN
Various Insulin Regimens for Diabetic Inpatients With Cirrhosis Trial
Lead Sponsor:
Cairo University
Collaborating Sponsors:
Sanofi
Conditions:
Type 2 Diabetes
Liver Cirrhosis
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
Liver disease is an important cause of death in type 2 diabetes. In the population-based Verona Diabetes Study cirrhosis was the fourth leading cause of death and accounted for 4.4% of diabetes-relate...
Detailed Description
Best management of hyperglycemia in non-intensive care unit Cirrhotic patients with type 2 diabetes by different insulin regimens either sliding scale regular insulin or basal bolus insulin using NPH ...
Eligibility Criteria
Inclusion
- Hospitalized type 2 Diabetes Mellitus with liver cirrhosis
- Entry blood glucose (fasting or random) greater than 180 mg%
Exclusion
- Type 1 Diabetes Mellitus
- Pregnancy
- Steroids: prednisone greater than 7.5mg/day or equivalent
- Serum Creatinine \> 3 mg/dl
- Patients in intensive care units.
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2011
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT01143948
Start Date
January 1 2011
End Date
May 1 2011
Last Update
June 15 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Internal medicine hospital ,Cairo University
Cairo, Cairo Governorate, Egypt, 11956